ASH 2023 | The promise of gene therapies in SCD and important practical considerations for these agents
Rabi Hanna
• 11 Dec 2023
In this video, Rabi Hanna, MD, Cleveland Clinic, Cleveland, OH, briefly discusses the excitement surrounding novel gene therapies in sickle cell disease (SCD), highlighting the caution that must be taken with these agents. Dr Hanna also comments on the need to improve accessibility to these potentially transformative therapies. This interview took place at the 65th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Speakers Bureau: SOBI, Sanofi
Honoraria: Vertex
Research Funding: EDITAS
